Is CTSH a Buy? What to Consider in 2026

Short answer

The bull case for Cognizant Technology Solutions (CTSH) rests on AI-led services and deal momentum: Cognizant is repositioning around generative AI, agentic automation, and cloud/data modernization, and reported first-quarter 2026 bookings up 21% with seven deals over $100 million and one mega deal above $500 million. Revenue (TTM) is ~$21.4B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: The core risk is that AI automation erodes the labor-arbitrage economics of traditional IT services, pressuring pricing and headcount-linked revenue over time. Whether CTSH is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

Cognizant Technology Solutions is one of the largest global IT services and consulting firms, with roughly 357,600 employees (as of April 2026) and a delivery model centered on India-based talent serving mostly North American and European clients. It builds, runs, and modernizes software and business processes across four segments, Health Sciences, Financial Services, Products and Resources, and Communications, Media and Technology, and is increasingly positioning around generative AI, cloud migration, and data services (including a roughly $600 million acquisition of AI-infrastructure provider Astreya). The investment picture is a classic value-versus-growth tension. As of July 2026 Cognizant carries a market cap near $25 billion against about $21.4 billion in trailing revenue and roughly $2.2 billion in net income, giving a trailing P/E around 11 to 12 and a forward P/E near 9, cheap relative to premium peer Accenture. Bookings momentum is strong (trailing bookings up 11% to $29.6 billion, a 1.4x book-to-bill), and management is expanding margins through the Project Leap restructuring, but clients are trimming discretionary spending and the long-term question is whether AI automation compresses the labor-arbitrage model that IT services has run on for decades.

What's the case for buying CTSH?

1. AI-led services and deal momentum

Cognizant is repositioning around generative AI, agentic automation, and cloud/data modernization, and reported first-quarter 2026 bookings up 21% with seven deals over $100 million and one mega deal above $500 million. Trailing bookings of $29.6 billion at a 1.4x book-to-bill (as of April 2026) suggest a healthy pipeline. The bet is that enterprises route AI adoption budgets through large systems integrators like Cognizant.

2. Margin expansion via Project Leap

Management launched Project Leap, a multi-year operational-excellence program targeting $200 million to $300 million in annual savings by the end of 2026, partly by simplifying the operating model and automating internal work (including roughly 4,000 role reductions). It raised 2026 adjusted operating-margin guidance to 16.0% to 16.2% (as of April 2026). Steady margin gains support the adjusted EPS guide of $5.63 to $5.77.

3. Valuation, dividend, and buybacks

CTSH trades at a low double-digit trailing P/E and roughly 9x forward earnings (as of July 2026), a discount to premium peers. The company returns cash through a quarterly dividend and ongoing share repurchases, and generates substantial free cash flow. That combination is what draws value-oriented and income-tilted investors to the name.

4. Acquisitions extending capability

Cognizant is buying AI-infrastructure and data-center services provider Astreya for about $600 million (announced 2026) to strengthen AI-ready delivery, continuing a pattern of bolt-on deals that add capabilities in health, data, and engineering. These acquisitions aim to move revenue mix toward higher-value, AI-adjacent work rather than commoditized staffing.

What are the risks to CTSH?

The core risk is that AI automation erodes the labor-arbitrage economics of traditional IT services, pressuring pricing and headcount-linked revenue over time. Near-term demand is soft: clients are cutting discretionary spending, delaying projects, and focusing on cost, with the Q2 2026 revenue guide implying only modest sequential growth (as of April 2026). Cognizant also faces intense competition and pricing pressure from larger peer Accenture and India-based rivals such as TCS, Infosys, Wipro, and HCL. Client concentration in banking, financial services, and health sciences means a downturn in those verticals hits results, and a large share of delivery in India exposes the company to wage inflation, currency swings, immigration/visa policy, and geopolitical risk. Execution on Project Leap and integrating acquisitions add further uncertainty.

How is CTSH valued? (as of JULY 2026)

Price

$43.51

Market cap

$20.58B

P/E (TTM)

9.44

Forward P/E

7.03

Price / book

1.37

Beta

0.86

52-week range

$37.08 to $87.03

Snapshot for CTSH as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (TTM): ~$21.4B
Net income (TTM): ~$2.2B
Market cap: ~$25B
Trailing P/E: ~11-12x
Forward P/E: ~9x
2026 adj. EPS guidance: ~$5.63-$5.77

As of July 2026, CTSH's valuation is notably low for a profitable large-cap, reflecting the market's skepticism about IT-services growth in an AI world after the stock fell sharply during 2026. First-quarter 2026 revenue rose 5.8% year over year to $5.413 billion, and full-year 2026 revenue is guided to roughly $22.1 billion to $22.6 billion. Figures are approximate and change with each quarterly report and share-price move.

How do you decide if CTSH is a buy?

Rather than asking whether CTSH is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold CTSH indirectly through an index or sector ETF before adding more.

For the full picture, see the CTSH stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CTSH against your real portfolio and see your actual exposure before deciding.

The bottom line on CTSH

The bottom line: Cognizant Technology Solutions's story right now is AI-led services and deal momentum, with revenue (ttm) at ~$21.4B. If you believe that narrative continues, the call is about sizing CTSH sensibly and checking overlap with what you own; if you doubt it (the risk: the core risk is that AI automation erodes the labor-arbitrage economics of traditional IT services, pressuring pricing and headcount-linked revenue over time.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around CTSH with Walnut

Use Cognizant Technology Solutions as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

Create a free Walnut account

FAQ

Is CTSH a good stock to buy right now?

The case for Cognizant Technology Solutions right now is AI-led services and deal momentum, with revenue (ttm) at ~$21.4B. If you believe that thesis holds, CTSH is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is the core risk is that AI automation erodes the labor-arbitrage economics of traditional IT services, pressuring pricing and headcount-linked revenue over time. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does Cognizant Technology Solutions do?

Cognizant Technology Solutions is one of the largest global IT services and consulting firms, with roughly 357,600 employees (as of April 2026) and a delivery model centered on Ind

What are the main risks of CTSH?

What does Cognizant actually do?

Cognizant provides IT services and consulting: it builds, modernizes, and runs software, cloud, data, and business processes for large enterprises. It serves clients across health sciences, financial services, products and resources, and communications/media/technology, largely from India-based delivery centers.

Is CTSH a growth stock or a value stock?

It reads as a value stock. As of July 2026 it trades at a low double-digit trailing P/E and around 9x forward earnings with mid-single-digit revenue growth, so investors typically own it for cash generation and valuation rather than rapid expansion.

Does Cognizant pay a dividend?

Yes. Cognizant pays a regular quarterly cash dividend and also repurchases shares. As a mature, free-cash-flow-generative IT services firm, returning capital to shareholders is a core part of its financial profile.

How fast is Cognizant growing?

Revenue grew 5.8% year over year in the first quarter of 2026 to $5.413 billion (about 3.9% in constant currency), and full-year 2026 is guided to roughly 4.8% to 7.3% reported growth. That is mid-single-digit growth, typical for a large IT services incumbent.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell CTSH; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.